Late clinical presentation of congenital adrenal hyperplasia in older children: findings from national paediatric surveillance
Open Access
- 16 September 2013
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 99 (1), 30-34
- https://doi.org/10.1136/archdischild-2012-303070
Abstract
Objectives To describe the clinical presentation and sequelae, including salt-wasting crises of newly-diagnosed congenital adrenal hyperplasia (CAH) in children aged over 1 year in a contemporary population without screening. To appraise the potential benefit of newborn screening for late-presenting CAH. Design Active national surveillance undertaken in Great Britain prospectively from 2007–2009 through the British Paediatric Surveillance Unit. Setting England, Wales and Scotland. Patients Children first presenting aged 1–15 years with clinical features of CAH and elevated 17-hydroxyprogesterone. Results Fifty-eight children (26 [45%] boys) aged 1–15 years were reported; 50 (86%) had 21-hydroxylase deficiency. Diagnosis was precipitated by secondary sexual characteristics (n=38 [66%]; median age 5.8 [IQR] 4.8, 7.6) years, genital virilisation (8 girls; 3.2 [IQR 1.3, 7.3] years) or an affected sibling (n=8; 10.0 [IQR 7.4, 13.3] years). At least 33 (57%) children had advanced bone age and 13 (30%) were obese (body mass index ≥95th centile). No child had experienced a salt-wasting crisis. Conclusions In Great Britain, 30 children aged 1–15 years present annually for the first time with CAH. Older children frequently manifest prematurely advanced epiphyseal and pubertal maturation and genital virilisation, which are often irreversible and likely to have long-lasting consequences for adult health and wellbeing. Almost one-third of affected children are obese before commencing steroid therapy. Newborn screening offers the potential to avoid serious clinical manifestations in older children with unrecognised CAH; however, it may also detect some children who would otherwise remain asymptomatic and for whom the benefit from treatment is uncertain.Keywords
This publication has 23 references indexed in Scilit:
- Health Status of Adults with Congenital Adrenal Hyperplasia: A Cohort Study of 203 PatientsJournal of Clinical Endocrinology & Metabolism, 2010
- Congenital Adrenal Hyperplasia: Classification of Studies Employing Psychological EndpointsInternational Journal of Pediatric Endocrinology, 2010
- Two-year pilot study of newborn screening for congenital adrenal hyperlasia in New South Wales compared with nationwide case surveillance in AustraliaJournal of Paediatrics and Child Health, 2008
- How Many Deaths Can Be Prevented by Newborn Screening for Congenital Adrenal Hyperplasia?Hormone Research in Paediatrics, 2007
- Obesity Among Children and Adolescents With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase DeficiencyPEDIATRICS, 2006
- An Update of Congenital Adrenal HyperplasiaAnnals of the New York Academy of Sciences, 2004
- Newborn Screening for Congenital Adrenal Hyperplasia inthe NetherlandsPEDIATRICS, 2001
- Obesity in 21-hydroxylase deficient patientsArchives of Disease in Childhood, 1998
- Should we screen for congenital adrenal hyperplasia? A review of 117 cases.Archives of Disease in Childhood, 1987